OABI news today — last 24 hours, 7 days, 30 days

OMNIAB INC (OABI) — News & AI sentiment

OMNIAB INC (OABI) news roundup. 1 story in the past week, 4 over 30 days. Average 30-day sentiment is 61.3/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

7d stories

avg sentiment 56/100

30d stories

avg sentiment 61.3/100

Insider net (90d)

0 buys · 0 sells

Congress (90d)

0 buys · 0 sells

OABI news in the last 24 hours, 7 days, 30 days and 90 days

How much OABI coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	OABI stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	1	56/100	OABI headlines →
Last 30 days	4	61.3/100	OABI headlines →
Last 90 days	22	59.2/100	OABI headlines →

Latest stories on OABI

OmniAb to Host Investor & Analyst Day on October 6, 2026

StockTitan56 · neutralgeneral

4d ago

Is OmniAb (OABI)’s Eli Lilly (LLY) Partnership a Game Changer for OABI?

Yahoo Finance67 · bullishproduct/pr

Aug 28

OmniAb to Participate in Upcoming Investor Conferences

StockTitan55 · neutralgeneral

Aug 26

VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase

Business Insider67 · bullishproduct/pr

Aug 25

OmniAb Boosts 2026 Cash Outlook Following Technology Licensing Momentum August 18, 2026

MarketChameleon67 · bullishgeneral

Aug 18

OmniAb: Lilly-Style Partners Are Paying Attention To This Early-Stage Biotech

Seeking Alpha67 · bullishproduct/pr

Aug 18

OmniAb (OABI) Q2 2026 Earnings Call Transcript

Yahoo Finance67 · bullishearnings

Aug 14

OmniAb (OABI) Q2 2026 Earnings Call Transcript

The Motley Fool73 · bullishearnings

Aug 14

OmniAb Earnings Call Highlights Surging Growth, Clinical Wins

TipRanks67 · bullishearnings

Aug 8

OmniAb, Inc. 2026 Q2 - Results - Earnings Call Presentation

Seeking Alpha50 · neutralearnings

Aug 8

OmniAb, Inc. (OABI) Q2 2026 Earnings Call Transcript

Seeking Alpha50 · neutralearnings

Aug 7

OmniAb Q2 Earnings Call Highlights

Yahoo Top63 · neutralearnings

Aug 7

OmniAb GAAP EPS of -$0.05 beats by $0.07, revenue of $13.4M beats by $8.71M

Seeking Alpha68 · bullishearnings

Aug 7

Omniab Raises Fy26 Revenue View To 32m 36m From 28m 33m

The Fly63 · neutralgeneral

Aug 6

Omniab Reports Q2 Eps 5c Consensus 13c

The Fly28 · bearishearnings

Aug 6

OmniAb Reports Second Quarter 2026 Financial Results and Business Highlights

StockTitan50 · neutralgeneral

Aug 6

VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb

StockTitan63 · neutralproduct/pr

Jul 27

OmniAb to Report Second Quarter 2026 Financial Results on August 6 | OABI Stock News

StockTitan50 · neutralgeneral

Jul 16

OmniAb Names Amechi Nwachuku Chief Operating Officer

TipRanks56 · neutralgeneral

Jul 13

OmniAb, Inc. (OABI) files 8-K

SEC 8-K50 · neutralgeneral

Jul 13

OmniAb Names Amechi Nwachuku Chief Operating Officer | OABI Stock News

StockTitan63 · neutralproduct/pr

Jul 13

OmniAb (OABI) Gains More Than 38% Over 6 Months, Can It Go Higher?

Yahoo Top63 · neutralgeneral

Jul 3

OmniAb, Inc. (OABIW) files 8-K

SEC 8-K50 · neutralgeneral

Jun 18

OmniAb Q1 Earnings Call Highlights

Yahoo Finance50 · neutralearnings

May 8